Kobbi Zina is a Pharmacist and PhD student, with a broad and acute interest in drug development, regulation, and researches. Her long experience in pharmaceutical industry and researchers on biosimilars, lead her to be an expert in the field. She has done her Master’s degree in Drug Development and worked on therapeutic equivalence of generic products and BCS classification. She is pursuing her Ph.D. in Biosimilar Evaluation while working in an industry developing generics and biosimilars.   Kobbi Zina is a Pharmacist and PhD student, with a broad and acute interest in drug development, regulation, and researches. Her long experience in pharmaceutical industry and researchers on biosimilars, lead her to be an expert in the field. She has done her Master’s degree in Drug Development and worked on therapeutic equivalence of generic products and BCS classification. She is pursuing her Ph.D. in Biosimilar Evaluation while working in an industry developing generics and biosimilars.  

Her research works are mainly focused on the preclinical evaluation of a biosimilar  (enoxaparin) by performing in vitro comparative studies (physicochemical and biological) and in vivo comparative studies (toxicity and pharmacodynamics studies).